Company: HSDTW
Filing Date: 2025-03-25
Form Type: DEF 14A
Source: 0001558370-25-003622
Chunk: 4

Company: Solana Co
Filing Date: 2025-03-25
Form: DEF 14A
Chunk 4
---
 (the “ Board”) of Helius Medical Technologies, Inc. (the “ Company”, “ we” or “ us”) is soliciting your proxy, as a holder of our Class A common stock (the “ Common Stock”), for use at the 2025 Annual Meeting of Stockholders to be held on Monday, April 21, 2025, at 9:00 a.m. Eastern Time, virtually at www.virtualshareholdermeeting.com/HSDT2025 and any adjournment or postponement of such meeting (the “ Annual Meeting”). The Notice of Annual Meeting of Stockholders, proxy statement and form of proxy card are expected to be first mailed to stockholders of record on or about March 25, 2025. What is the purpose of the Annual Meeting? At the Annual Meeting, you will be voting on:

| ● | Proposal 1 – To elect six directors named in the accompanying proxy statement, each to serve for a one-year term until the 2026 annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal; |

| ● | Proposal 3 – To approve, pursuant to Nasdaq listing rules, the issuance of up to 6,213,888 shares of our common stock upon the exercise of existing Series C and Series D warrants to purchase common stock issued to warrantholders in connection with the Warrant Exercise and Inducement Letters dated January 21, 2025 (the “Inducement Warrant Proposal”); |

| ● | Proposal 4 – To approve an amendment to our Certificate of Incorporation to effect a reverse split of our outstanding Class A common stock at a ratio of 1 for 2 to 1 for 30 to be determined at the discretion of our Board of Directors, whereby each outstanding 2 to 30 shares would be combined, converted and changed into 1 share of our Class A common stock, to enable the Company to comply with the Nasdaq Stock Market’s continued listing requirements (the “Reverse Stock Split Proposal”); and |

| ● | Proposal 5 – To authorize one or more adjournments of the Annual Meeting to solicit additional proxies in the event there are insufficient votes to approve Proposals 3 or 4. |

The Board unanimously recommends that you vote FORthe election of each director nominee and FORProposals 2, 3, 4 and 5. What if another matter is properly brought before the Annual Meeting? The Board